Clinical Trials Browser

Differentiated Thyroid Cancer × lenvatinib × 90 days × Clear all

NCT04321954 2026-02-27

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Phase 2 Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer